ARGX vs BIIB: stock comparison and AI forecast
Argenx Se (ARGX) and Biogen Inc. (BIIB) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARGX Argenx Se
- Market Cap
- $55.76B
- P/E Ratio
- 23.6x
- Size
- large-cap
- AI Forecast
BIIB Biogen Inc.
- Price
- $249.01 +33.0% · 6M
- Market Cap
- $36.80B
- P/E Ratio
- 107.3x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ARGX is 1.5 times larger than BIIB by market capitalization ($55.76B against $36.80B).
- ARGX trades at 23.6 times trailing earnings, BIIB at 107.3 times.
- BIIB carries 0.69 times debt per unit of equity, against 0.19 times for ARGX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARGX | BIIB |
|---|---|---|
| Market Cap | $55.76B | $36.80B |
| P/E Ratio | 23.64x | 107.30x |
| P/B Ratio | – | 1.94x |
| EPS | $38.12 | $2.32 |
| Book Value/Share | – | $128.01 |
| Revenue/Share | – | $69.66 |
| FCF/Share | $13.34 | $14.01 |
Profitability & Margins
| Metric | ARGX | BIIB |
|---|---|---|
| ROE | 34.2% | 1.8% |
| ROA | 28.9% | 1.1% |
| ROIC | 16.8% | – |
| Gross Margin | – | 74.0% |
| Net Margin | – | 3.4% |
| EBT Margin | – | 4.3% |
| Tax Rate | -42.2% | 21.9% |
Financial Health
| Metric | ARGX | BIIB |
|---|---|---|
| Current Ratio | 5.23x | 1.95x |
| Quick Ratio | 4.87x | 1.37x |
| D/E Ratio | 0.19x | 0.69x |
| Financial Leverage | 1.19x | 1.69x |
| Interest Coverage | – | 9.2x |
| Working Capital | $5.58B | $3.69B |
Cash Flow
| Metric | ARGX | BIIB |
|---|---|---|
| Operating Cash Flow | $840M | $2.25B |
| Free Cash Flow | $826M | $2.07B |
| Capital Spending | -$14M | -$176M |
| OCF Growth YoY | – | -8.4% |
| FCF Growth YoY | 0.0% | -10.1% |
| FCF/Sales | – | 20.1% |
| CapEx/Sales | – | 1.7% |
Operational Efficiency
| Metric | ARGX | BIIB |
|---|---|---|
| Asset Turnover | – | 0.32x |
| Inventory Turnover | 2.0x | 1.2x |
| Fixed Assets Turnover | – | 3.5x |
| Days Inventory | 179 days | 303 days |
| Payables Period | 479 days | 59 days |
Income Statement
| Metric | ARGX | BIIB |
|---|---|---|
| Total Revenue | – | $10.30B |
| Operating Income | $1.23B | – |
| Net Income | $2.51B | $348M |
| R&D Expense | $3.43B | $2.15B |
| SG&A Expense | $3.52B | $2.75B |
| Cost of Goods Sold | $965M | $2.68B |
Dividend & Shareholder Information
| Metric | ARGX | BIIB |
|---|---|---|
| Shares Outstanding | 62M | 148M |
| Net Income Growth | – | -78.4% |
| EPS Growth | – | -78.8% |
ARGX vs BIIB: stock comparison and AI forecast
Which is bigger, ARGX or BIIB?
ARGX is 1.5 times larger than BIIB by market capitalization ($55.76B against $36.80B).
Which is cheaper on earnings, ARGX or BIIB?
ARGX trades at 23.6 times trailing earnings, BIIB at 107.3 times.
Which one does Intratio's AI model rank higher, ARGX or BIIB?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.